Viewing Study NCT02125435


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2025-12-30 @ 1:22 AM
Study NCT ID: NCT02125435
Status: COMPLETED
Last Update Posted: 2014-04-29
First Post: 2014-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects
Sponsor: Astellas Pharma Global Development, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module